Review
Published on 10 May 2023
The critical role of mode of action studies in kinetoplastid drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1185679
- 3,886 views
- 8 citations
Type at least 3 characters
20 articles
Editorial
Published on 27 Feb 2023
Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1157688
- 1,370 views
- 2 citations
Original Research
Published on 10 Feb 2023
HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1112992
- 2,091 views
Brief Research Report
Published on 05 Jan 2023
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1082065
- 3,782 views
- 6 citations
Review
Published on 07 Dec 2022
The landscape of nature-derived antimalarials-potential of marine natural products in countering the evolving Plasmodium
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1065231
- 4,256 views
- 6 citations
Original Research
Published on 21 Oct 2022
A machine learning-based virtual screening for natural compounds capable of inhibiting the HIV-1 integrase
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.954911
- 5,967 views
- 11 citations
Original Research
Published on 20 Oct 2022
From drugs to targets: Reverse engineering the virtual screening process on a proteomic scale
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969983
- 6,243 views
- 11 citations
Review
Published on 12 Oct 2022
Chemically induced phenotypes during the blood stage development of Plasmodium falciparum as indicators of the drug mode of action
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.920850
- 6,158 views
- 5 citations
Original Research
Published on 23 Sep 2022
Integrating diverse layers of omic data to identify novel drug targets in Listeria monocytogenes
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969415
- 2,917 views
- 7 citations
Original Research
Published on 31 Aug 2022
Bismuth subsalicylate as potential treatment for Covid-19 pneumonia: A case series report
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.962988
- 17,740 views
Brief Research Report
Published on 29 Aug 2022
Antifungal properties of (2S, 4R)-Ketoconazole sulfonamide analogs
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1000827
- 1,965 views
- 2 citations
Review
Published on 26 Aug 2022
The challenges and opportunities for the development of COVID-19 therapeutics and preparing for the next pandemic
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.925825
- 8,301 views
- 1 citation
Mini Review
Published on 18 Jul 2022
Nanobodies: COVID-19 and Future Perspectives
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.927164
- 10,440 views
- 15 citations
Clinical Trial
Published on 15 Jul 2022
Reszinate—A Phase 1/2 Randomized Clinical Trial of Zinc and Resveratrol Utilizing Home Patient-Obtained Nasal and Saliva Viral Sampling
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.910124
- 5,303 views
- 1 citation
Perspective
Published on 30 May 2022
Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.892975
- 8,499 views
- 20 citations
Review
Published on 02 May 2022
Advances in Modelling COVID-19 in Animals
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.899587
- 10,583 views
- 1 citation